SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001698530-23-000098
Filing Date
2023-08-23
Accepted
2023-08-23 09:29:26
Documents
14
Period of Report
2023-08-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20230823.htm   iXBRL 8-K 35753
2 EX-99.1 a8k823-exhibit991.htm EX-99.1 9241
6 exicureimage1a10.gif GRAPHIC 2794
  Complete submission text file 0001698530-23-000098.txt   184337

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20230823.xsd EX-101.SCH 1907
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20230823_lab.xml EX-101.LAB 24833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20230823_pre.xml EX-101.PRE 13047
8 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20230823_htm.xml XML 2802
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 231195437
SIC: 2834 Pharmaceutical Preparations